{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:33:39Z","timestamp":1778776419742,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02802 JP22K21351"],"award-info":[{"award-number":["21H02802 JP22K21351"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJCR1655"],"award-info":[{"award-number":["JPMJCR1655"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21zf0127005"],"award-info":[{"award-number":["JP21zf0127005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Insomnia is associated with psychiatric illnesses such as bipolar disorder or schizophrenia. Treating insomnia improves psychotic symptoms severity, quality of life, and functional outcomes. Patients with psychiatric disorders are often dissatisfied with the available therapeutic options for their insomnia. In contrast, positive allosteric modulation of adenosine A<jats:sub>2A<\/jats:sub> receptors (A<jats:sub>2A<\/jats:sub>Rs) leads to slow-wave sleep without cardiovascular side effects in contrast to A<jats:sub>2A<\/jats:sub>R agonists.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We investigated the hypnotic effects of A<jats:sub>2A<\/jats:sub>R positive allosteric modulators (PAMs) in mice with mania-like behavior produced by ablating GABAergic neurons in the ventral medial midbrain\/pons area and in a mouse model of schizophrenia by knocking out of microtubule-associated protein 6. We also compared the properties of sleep induced by A<jats:sub>2A<\/jats:sub>R PAMs in mice with mania-like behavior with those induced by DORA-22, a dual orexin receptor antagonist that improves sleep in pre-clinical models, and the benzodiazepine diazepam.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A<jats:sub>2A<\/jats:sub>R PAMs suppress insomnia associated with mania- or schizophrenia-like behaviors in mice. A<jats:sub>2A<\/jats:sub>R PAM-mediated suppression of insomnia in mice with mania-like behavior was similar to that mediated by DORA-22, and, unlike diazepam, did not result in abnormal sleep.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> A<jats:sub>2A<\/jats:sub>R allosteric modulation may represent a new therapeutic avenue for sleep disruption associated with bipolar disorder or psychosis.<\/jats:p>","DOI":"10.3389\/fphar.2023.1138666","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:35:54Z","timestamp":1681878954000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Yang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koustav","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Ioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Amezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoan","family":"Cherasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh K.","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Klewe-Nebenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1101\/gad.223302","article-title":"The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders","volume":"16","author":"Andrieux","year":"2002","journal-title":"Genes Dev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00002826-200009000-00008","article-title":"Abuse, dependence, and epileptic seizures after zolpidem withdrawal: Review and case report","volume":"23","author":"Aragona","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1471-4159.2005.03166.x","article-title":"Dopaminergic transmission in STOP null mice","volume":"94","author":"Brun","year":"2005","journal-title":"J. Neurochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1021\/jm100541c","article-title":"Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl] [5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia","volume":"53","author":"Cox","year":"2010","journal-title":"J. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molmed.2011.08.004","article-title":"Targeting glutamate synapses in schizophrenia","volume":"17","author":"Field","year":"2011","journal-title":"Trends Mol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1186\/s12889-020-09250-y","article-title":"Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015-2017","volume":"20","author":"Ghosh","year":"2020","journal-title":"BMC Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: Prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int. J. Bipolar Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1037\/a0038655","article-title":"Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: A pilot randomized controlled trial","volume":"83","author":"Harvey","year":"2015","journal-title":"J. Consult Clin. Psychol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: An endogenous regulator of innate immunity","volume":"25","author":"Hask\u00f3","year":"2004","journal-title":"Trends Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/jama.278.1.27","article-title":"Benzodiazepine use and the risk of motor vehicle crash in the elderly","volume":"278","author":"Hemmelgarn","year":"1997","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.isci.2020.101240","article-title":"Ablation of ventral midbrain\/pons GABA neurons induces mania-like behaviors with altered sleep homeostasis and dopamine D2R-mediated sleep reduction","volume":"23","author":"Honda","year":"2020","journal-title":"iScience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2115-1","article-title":"Dopamine D2 receptors in discrimination learning and spine enlargement","volume":"579","author":"Iino","year":"2020","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1586\/17512433.2014.966813","article-title":"Suvorexant for the treatment of insomnia","volume":"7","author":"Jacobson","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/NSS.S121076","article-title":"Schizophrenia and sleep disorders: Links, risks, and management challenges","volume":"9","author":"Kaskie","year":"2017","journal-title":"Nat. Sci. Sleep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"zsab043","DOI":"10.1093\/sleep\/zsab043","article-title":"Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice","volume":"44","author":"Kaushik","year":"2021","journal-title":"Sleep"},{"key":"B16","first-page":"163","article-title":"Premorbid characterization in schizophrenia: The pittsburgh high risk study","volume":"3","author":"Keshavan","year":"2004","journal-title":"World Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.sleep.2017.11.530","article-title":"Allosteric modulation of adenosine A2A receptors in mice induces slow-wave sleep without cardiovascular effects","volume":"40","author":"Korkutata","year":"2017","journal-title":"Sleep. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuropharm.2018.10.022","article-title":"Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function","volume":"144","author":"Korkutata","year":"2019","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"10067","DOI":"10.1523\/JNEUROSCI.6730-10.2011","article-title":"Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens","volume":"31","author":"Lazarus","year":"2011","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1038\/s41380-020-00906-0","article-title":"Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway","volume":"26","author":"Li","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/sleep\/31.4.489","article-title":"Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia","volume":"31","author":"Manber","year":"2008","journal-title":"Sleep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1097\/00003246-200009000-00014","article-title":"High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit. Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.biopsych.2015.02.026","article-title":"Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: Relevance to schizophrenia","volume":"78","author":"Matos","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R1715","DOI":"10.1152\/ajpregu.00247.2005","article-title":"Effects on sleep of microdialysis of adenosine A1 and A2A receptor analogs into the lateral preoptic area of rats","volume":"289","author":"Methippara","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e53678","DOI":"10.3791\/53678","article-title":"Polygraphic recording procedure for measuring sleep in mice","author":"Oishi","year":"2016","journal-title":"J. Vis. Exp."},{"key":"B26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41467-017-00781-4","article-title":"Slow-wave sleep is controlled by a subset of nucleus accumbens core neurons in mice","volume":"8","author":"Oishi","year":"2017","journal-title":"Nat. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/schbul\/sbw017","article-title":"Disruptions of sleep\/wake patterns in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia","volume":"42","author":"Profitt","year":"2016","journal-title":"Schizophr. Bull."},{"key":"B28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.sleep.2018.06.003","article-title":"How representative are insomnia clinical trials?","volume":"51","author":"Roehrs","year":"2018","journal-title":"Sleep. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuron.2006.09.015","article-title":"Neurobiology of schizophrenia","volume":"52","author":"Ross","year":"2006","journal-title":"Neuron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1460-9568.1999.00569.x","article-title":"Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist","volume":"11","author":"Satoh","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/s0306-4522(01)00383-9","article-title":"An adenosine A2A agonist increases sleep and induces Fos in ventrolateral preoptic neurons","volume":"107","author":"Scammell","year":"2001","journal-title":"Neuroscience"},{"key":"B32","first-page":"1821","article-title":"Schizophrenia: A review","volume":"75","author":"Schultz","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"B33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.schres.2006.03.017","article-title":"Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia","volume":"84","author":"Shimizu","year":"2006","journal-title":"Schizophr. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0006-2952(02)01548-4","article-title":"Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo","volume":"65","author":"Sitkovsky","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jsmc.2013.04.007","article-title":"Insomnia comorbid to severe psychiatric illness","volume":"8","author":"Soehner","year":"2013","journal-title":"Sleep. Med. Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/s0731-7085(00)00574-4","article-title":"HPLC determination of adenosine in human synovial fluid","volume":"24","author":"Sottofattori","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0165-5728(00)00365-9","article-title":"Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips","volume":"111","author":"Sperl\u00e1gh","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1523\/JNEUROSCI.0598-18.2018","article-title":"Sleep and wakefulness are controlled by ventral medial midbrain\/pons GABAergic neurons in mice","volume":"38","author":"Takata","year":"2018","journal-title":"J. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1212\/01.wnl.0000095222.41066.5e","article-title":"Sleep regulation in adenosine A2A receptor-deficient mice","volume":"61","author":"Urade","year":"2003","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000139363","article-title":"Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics","volume":"51","author":"Vgontzas","year":"1995","journal-title":"Pharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/schbul\/sbs113","article-title":"Reduced expression of STOP\/MAP6 in mice leads to cognitive deficits","volume":"39","author":"Volle","year":"2013","journal-title":"Schizophr. Bull."},{"key":"B42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuron.2011.05.028","article-title":"Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons","volume":"71","author":"Vong","year":"2011","journal-title":"Neuron"},{"key":"B43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrd2464","article-title":"Emerging anti-insomnia drugs: Tackling sleeplessness and the quality of wake time","volume":"7","author":"Wafford","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/s41380-020-0810-9","article-title":"Dysfunction of ventral tegmental area GABA neurons causes mania-like behavior","volume":"26","author":"Yu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B45","first-page":"52","article-title":"Antipsychotic drug side effect issues in bipolar manic patients","volume":"61","author":"Zarate","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuint.2019.01.020","article-title":"Extracellular adenosine and slow-wave sleep are increased after ablation of nucleus accumbens core astrocytes and neurons in mice","volume":"124","author":"Zhou","year":"2019","journal-title":"Neurochem. Int."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1138666\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:36:00Z","timestamp":1681878960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1138666\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":46,"alternative-id":["10.3389\/fphar.2023.1138666"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1138666","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"article-number":"1138666"}}